The end of aspirin for dementia prevention in diabetes?

Eur Heart J. 2022 Jun 1;43(21):2020-2022. doi: 10.1093/eurheartj/ehac211.

Authors

Steen D Kristensen^{1

2}, Kevin K W Olesen¹, Michael Maeng^{1

2}

Affiliations

¹ Department of Cardiology, Aarhus University Hospital, Aarhus N, Denmark.
² Institute of Clinical Medicine, Faculty of Health, Aarhus University, Aarhus N, Denmark.

PMID: 35452114
DOI: 10.1093/eurheartj/ehac211

No abstract available

Publication types

Editorial
Comment

MeSH terms

Aspirin / therapeutic use
Cardiovascular Diseases* / prevention & control
Cognition
Dementia* / prevention & control
Diabetes Mellitus*
Humans
Platelet Aggregation Inhibitors / therapeutic use

Substances

Platelet Aggregation Inhibitors
Aspirin